Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-24
1997-06-03
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546201, A61K 31445, C07D40104
Patent
active
056355173
ABSTRACT:
1-Oxo- and 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl) isoindolines substituted with amino in the benzo ring reduce the levels of TNF.alpha. in a mammal. A typical embodiment is 1,3-dioxo-2-(2,6-dioxopiperidin-3-yl)-5-aminoisoindoline.
REFERENCES:
patent: 5385901 (1995-01-01), Kaplan et al.
patent: 5463083 (1995-10-01), Muller
N. Ake Jonsson, Chemical Structure and Teratogenic Properties: A Review Of Available Data On Structure-Activity Relationships and Mechanism Of Action Of Thalidomide Analogues, Acta Pharm. Suicica, vol. 9, pp. 521-542 (1972).
H. Koch, The Arene Oxide Hypothesis Of Thalidomide Action. Considerations On the Molecular Mechanism Of Action Of the Classical Teratogen, Sci. Pharm., vol. 49, pp. 67-99 (1981).
L. Sekut et al., Pathophysiology and Regulation Of TNF-.alpha. In Inflammation, DN&P 9(5), pp. 261-269, (1996).
Smith, R.L.; Fabro, S.; Schumacher, H. and William, R.T.; Studies on the relationship between the Chemical Structured and Embryotoxic Activity Of Thalidomide and Related Compounds. A Symposium on Embryotoxic Activity of dough, edited by Pobinson, J.M. et al. 1965, pp. 194-209. See p. 202, Table 6.
Chen Roger S.-C.
Muller George W.
Stirling David I.
Aulakh C. S.
Celgene Corporation
Ivy C. Warren
LandOfFree
Method of reducing TNF.alpha. levels with amino substituted 2-(2 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of reducing TNF.alpha. levels with amino substituted 2-(2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of reducing TNF.alpha. levels with amino substituted 2-(2 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-391950